EE214 The Cost-Effectiveness of Abemaciclib Combined With Endocrine Therapy (ET) for the Treatment of Persons With HR+, HER2- Node Positive, Early Breast Cancer (EBC) at High Risk of Recurrence: A Spanish Healthcare Perspective

Saved in:
Bibliographic Details
Published in:Value in health 2023-12, Vol.26 (12), p.S92
Main Authors: Davie, A., Molero, A., Goel, B.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2023.09.482